BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 31243493)

  • 1. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pruritus in systemic diseases : Common and rare etiologies].
    Kremer AE; Mettang T
    Hautarzt; 2016 Aug; 67(8):606-14. PubMed ID: 27376752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of chronic itch in systemic disease. Current standards].
    Mettang T; Ständer S; Kremer AE
    Internist (Berl); 2015 Dec; 56(12):1369-78. PubMed ID: 26585238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
    Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
    Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
    Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
    J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itch Management: Treatments under Development.
    Pereira MP; Ständer S
    Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are new treatment concepts in systemic itch?
    Kremer AE
    Exp Dermatol; 2019 Dec; 28(12):1485-1492. PubMed ID: 31452276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic pruritus.
    Mettang T; Kremer AE
    Kidney Int; 2015 Apr; 87(4):685-91. PubMed ID: 24402092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of pruritus in cholestasis.
    Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
    Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for pruritus in adult palliative care patients.
    Xander C; Meerpohl JJ; Galandi D; Buroh S; Schwarzer G; Antes G; Becker G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008320. PubMed ID: 23749733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Uremic Pruritus: A Systematic Review.
    Simonsen E; Komenda P; Lerner B; Askin N; Bohm C; Shaw J; Tangri N; Rigatto C
    Am J Kidney Dis; 2017 Nov; 70(5):638-655. PubMed ID: 28720208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uremic pruritus: an unresolved challenge].
    Aucella F; Gesuete A
    G Ital Nefrol; 2009; 26(5):585-99. PubMed ID: 19802804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients.
    Nakao K; Mochizuki H
    Drugs Today (Barc); 2009 May; 45(5):323-9. PubMed ID: 19584962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itch Management in the Elderly.
    Leslie TA
    Curr Probl Dermatol; 2016; 50():192-201. PubMed ID: 27578088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging drugs for the treatment of pruritus.
    Ständer S; Weisshaar E; Raap U
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nalfurafine, a kappa opioid receptor agonist, inhibits scratching behavior secondary to cholestasis induced by chronic ethynylestradiol injections in rats.
    Inan S; Cowan A
    Pharmacol Biochem Behav; 2006 Sep; 85(1):39-43. PubMed ID: 16919318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
    Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
    Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.
    Inan S; Dun NJ; Cowan A
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic Itch Management.
    Mettang T
    Curr Probl Dermatol; 2016; 50():133-41. PubMed ID: 27578082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of cholestatic pruritus.
    Bolier AR; Peri S; Oude Elferink RP; Beuers U
    Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.